Cell Cycle

3.5(top 10%)

impact factor

8.2K(top 2%)

papers

310.4K(top 2%)

citations

174(top 2%)

h-index

3.9(top 10%)

impact factor

10.4K

all documents

328.2K

doc citations

252(top 2%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma	Cell Cycle	2009	1,130
2	Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest	Cell Cycle	2007	859
3	How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?	Cell Cycle	2009	804
4	Partial inhibition of Cdk1 in G₂phase overrides the SAC and decouples mitotic events	Cell Cycle	2014	773
5	Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer	Cell Cycle	2008	725
6	Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression	Cell Cycle	2003	722
7	Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type	Cell Cycle	2006	721
8	The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype	Cell Cycle	2009	708
9	Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties	Cell Cycle	2006	615
10	Thelet-7microRNA reduces tumor growth in mouse models of lung cancer	Cell Cycle	2008	588
11	γH2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization	Cell Cycle	2010	545
12	miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions	Cell Cycle	2011	539
13	Ketones and lactate “fuel” tumor growth and metastasis	Cell Cycle	2010	526
14	DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells	Cell Cycle	2008	515
15	Resveratrol: A multitargeted agent for age-associated chronic diseases	Cell Cycle	2008	488
16	ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance	Cell Cycle	2015	482
17	mTOR complex 2 signaling and functions	Cell Cycle	2011	469
18	MicroRNAs as regulators of epithelial-mesenchymal transition	Cell Cycle	2008	467
19	Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro	Cell Cycle	2009	467
20	The Tubulin Code	Cell Cycle	2007	462
21	Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance	Cell Cycle	2009	460
22	Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch	Cell Cycle	2006	450
23	p53: Guardian of the Genome and Policeman of the Oncogenes	Cell Cycle	2007	440
24	Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform	Cell Cycle	2011	440
25	Oncogenic Mutations of PIK3CA in Human Cancers	Cell Cycle	2004	435
26	MiR-34, SIRT1, and p53: The feedback loop	Cell Cycle	2009	425
27	The Akt kinases: Isoform specificity in metabolism and cancer	Cell Cycle	2009	424
28	Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression	Cell Cycle	2016	417
29	Role of the c subunit of the F_OATP synthase in mitochondrial permeability transition	Cell Cycle	2013	416
30	Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution	Cell Cycle	2010	400
31	NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets	Cell Cycle	2009	399
32	mTOR coordinates protein synthesis, mitochondrial activity and proliferation	Cell Cycle	2015	397
33	Rapamycin decelerates cellular senescence	Cell Cycle	2009	395
34	Evidence for a stromal-epithelial “lactate shuttle” in human tumors	Cell Cycle	2011	393
35	MicroRNAs: Critical Regulators of Development, Cellular Physiology and Malignancy	Cell Cycle	2005	388
36	Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression	Cell Cycle	2009	386
37	Cysteine Cathepsins and the Cutting Edge of Cancer Invasion	Cell Cycle	2007	382
38	ATM Activation and DNA Damage Response	Cell Cycle	2007	382
39	Microvesicles: Messengers and mediators of tumor progression	Cell Cycle	2009	379
40	Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives	Cell Cycle	2005	377
41	Autophagy in cancer associated fibroblasts promotes tumor cell survival	Cell Cycle	2010	377
42	Metformin induces unique biological and molecular responses in triple negative breast cancer cells	Cell Cycle	2009	376
43	Single-vector inducible lentiviral RNAi system for oncology target validation	Cell Cycle	2009	367
44	Aging: ROS or TOR	Cell Cycle	2008	363
45	Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?	Cell Cycle	2007	360
46	Bioelectric controls of cell proliferation: Ion channels, membrane voltage and the cell cycle	Cell Cycle	2009	359
47	Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression	Cell Cycle	2003	357
48	Growth stimulation leads to cellular senescence when the cell cycle is blocked	Cell Cycle	2008	355
49	Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids	Cell Cycle	2009	345
50	Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6	Cell Cycle	2009	339

Scientometrics

Overviews

Citing Bodies

Cell Cycle

Top Articles